![](/img/cover-not-exists.png)
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Long, Georgina V, Dummer, Reinhard, Hamid, Omid, Gajewski, Thomas F, Caglevic, Christian, Dalle, Stephane, Arance, Ana, Carlino, Matteo S, Grob, Jean-Jacques, Kim, Tae Min, Demidov, Lev, Robert, CarolLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(19)30274-8
Date:
June, 2019
File:
PDF, 1.03 MB
english, 2019